Executive Briefings | April 30, 2022
Depression – Increasing Prevalence, New Science
Depression is no small matter in the United States. Approximately one in six Americans are on psychiatric medication (many of them antidepressants), including more than a quarter of those as long-term users (see Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race). And the prevalence of depression took a big upswing during the pandemic with 24.0% of people worldwide experiencing depression during the onset of COVID-19 (see <a href="https://openminds.com/market-intelligence/news/covid-19-mitigation-measures-impact . . .